GB0500643D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0500643D0
GB0500643D0 GBGB0500643.2A GB0500643A GB0500643D0 GB 0500643 D0 GB0500643 D0 GB 0500643D0 GB 0500643 A GB0500643 A GB 0500643A GB 0500643 D0 GB0500643 D0 GB 0500643D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0500643.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0500643.2A priority Critical patent/GB0500643D0/en
Publication of GB0500643D0 publication Critical patent/GB0500643D0/en
Priority to CA002594798A priority patent/CA2594798A1/en
Priority to EP10182870A priority patent/EP2332566A1/en
Priority to US11/795,135 priority patent/US20080139478A1/en
Priority to EP06701354.0A priority patent/EP1858544B1/en
Priority to PCT/GB2006/000051 priority patent/WO2006075138A2/en
Priority to JP2007550830A priority patent/JP2008526935A/ja
Priority to HK07113291.2A priority patent/HK1105366B/en
Priority to AU2006205696A priority patent/AU2006205696C1/en
Priority to US13/317,030 priority patent/US20120238505A1/en
Priority to JP2012165481A priority patent/JP2012211185A/ja
Priority to US14/487,838 priority patent/US20150218222A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0500643.2A 2005-01-13 2005-01-13 Medicaments Ceased GB0500643D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
AU2006205696A AU2006205696C1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing
EP06701354.0A EP1858544B1 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
EP10182870A EP2332566A1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing
US11/795,135 US20080139478A1 (en) 2005-01-13 2006-01-06 IL-10 Related Peptides For Wound Healing
CA002594798A CA2594798A1 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
JP2007550830A JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのｉｌ−１０関連ペプチド
HK07113291.2A HK1105366B (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
US13/317,030 US20120238505A1 (en) 2005-01-13 2011-10-07 Medicaments
JP2012165481A JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのｉｌ−１０関連ペプチド
US14/487,838 US20150218222A1 (en) 2005-01-13 2014-09-16 Medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments

Publications (1)

Publication Number Publication Date
GB0500643D0 true GB0500643D0 (en) 2005-02-23

Family

ID=34224534

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0500643.2A Ceased GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments

Country Status (7)

Country Link
US (3) US20080139478A1 (enExample)
EP (2) EP2332566A1 (enExample)
JP (2) JP2008526935A (enExample)
AU (1) AU2006205696C1 (enExample)
CA (1) CA2594798A1 (enExample)
GB (1) GB0500643D0 (enExample)
WO (1) WO2006075138A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
EP2451780B1 (en) 2009-07-06 2013-06-19 AstraZeneca AB Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
EP2691515A2 (en) * 2011-03-31 2014-02-05 President and Fellows of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
US20160287744A1 (en) 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
CA2905182A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CA2995120A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
MX9606537A (es) * 1994-07-05 1997-12-31 Steeno Res Group As Inmunomoduladores.
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Also Published As

Publication number Publication date
AU2006205696A1 (en) 2006-07-20
HK1105366A1 (en) 2008-02-15
WO2006075138A2 (en) 2006-07-20
US20120238505A1 (en) 2012-09-20
EP2332566A1 (en) 2011-06-15
EP1858544A2 (en) 2007-11-28
CA2594798A1 (en) 2006-07-20
US20150218222A1 (en) 2015-08-06
WO2006075138A3 (en) 2006-10-19
JP2012211185A (ja) 2012-11-01
JP2008526935A (ja) 2008-07-24
AU2006205696C1 (en) 2012-01-19
US20080139478A1 (en) 2008-06-12
EP1858544B1 (en) 2014-03-05
AU2006205696B2 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
GB0520794D0 (en) Inhaler
GB0519151D0 (en) Inhaler
AP2008004533A0 (en) Pharmaceutical combination
EP1859828A4 (en) INHALER
DE602006003064D1 (en) Tripeptid- und tetrapeptid-thioether
EP1862192A4 (en) INHALER
GB0501224D0 (en) I-Bell
ZA200804666B (en) Pharmaceutical combination
GB0507003D0 (en) Therapeutic
GB0511204D0 (en) Medicaments
DE602006021558D1 (en) Modulare montgomery-multiplikationseinrichtung
GB0402491D0 (en) Medicaments
EP1865780A4 (en) MINI OVEN
GB0613031D0 (en) Medicaments
EP1853258A4 (en) DRUGS
GB0403733D0 (en) Medicaments
TWI372053B (en) Combination drug
GB0518439D0 (en) Soother
GB0512246D0 (en) Novel pharmaceutical
DE502006004337D1 (en) Strangführungsrolle
GB0510091D0 (en) Inhaler
GB0524349D0 (en) Stratecut
GB0514260D0 (en) Medicaments
GB0502541D0 (en) Medicament
GB0407660D0 (en) Medicaments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)